We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current VTVT market cap is 86.99M. The company's latest EPS is USD -6.7271 and P/E is -4.31.
| Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 9k | 0 | 0 | 0 | 0 |
| Operating Income | -6.34M | -7.43M | -8M | -5.37M | -4.71M |
| Net Income | -4.75M | -4.5M | -5.62M | -6.65M | -3.48M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 2.76M | 6.41M | 4.01M | 2.02M | 0 |
| Operating Income | -20.89M | -11.85M | -21.66M | -22.54M | -25.5M |
| Net Income | -13.04M | -8.5M | -12.99M | -19.16M | -20.25M |
| Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 33.24M | 28.83M | 22.43M | 14.92M | 11.02M |
| Total Liabilities | 27.4M | 28.42M | 28.83M | 29.44M | 29.57M |
| Total Equity | -10.74M | -19.19M | -25.28M | -25.23M | -24.68M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 9.27M | 14.79M | 25.47M | 33.24M | 11.02M |
| Total Liabilities | 18.11M | 11M | 10.25M | 27.4M | 29.57M |
| Total Equity | -49.02M | -80.1M | -9.74M | -10.74M | -24.68M |
| Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -16.02M | -5.17M | -11.33M | -16.17M | -19.08M |
| Investing | -21k | N/A | N/A | N/A | 4.4M |
| Financing | 14.75M | 11.81M | 11.81M | 12.28M | 12M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -23.02M | -18M | -19.31M | -16.02M | -19.08M |
| Investing | 242k | N/A | N/A | -21k | 4.4M |
| Financing | 22.87M | 19.47M | 26.98M | 14.75M | 12M |
| Market Cap | 86.99M |
| Price to Earnings Ratio | -4.31 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 9.24 |
| Price to Book Ratio | -4.7 |
| Dividend Yield | - |
| Shares Outstanding | 3.01M |
| Average Volume (1 week) | 5.97k |
| Average Volume (1 Month) | 5.46k |
| 52 Week Change | -24.74% |
| 52 Week High | 39.60 |
| 52 Week Low | 7.38 |
| Spread (Intraday) | 3.56 (12.27%) |
| Company Name | vTv Therapeutics Inc |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://vtvtherapeutics.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
